Evidence map›Paper›PMID 35545638›Full record

ArticleScientific reports2022

Evaluation of protein production in rice seedlings under dark conditions.

Akiko Watanabe, Yoshino Hatanaka, Yukino Takeshima, Karin Sasaki, Noa Takahashi, Yukihiro Ito

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Akiko WatanabeGraduate School of Agricultural Science, Tohoku University, Sendai, 980-8572, Japan.
Yoshino HatanakaExploring-Germination-and-Growth Program for Young Scientists, Tohoku University, Sendai, 980-8579, Japan.
Yukino TakeshimaExploring-Germination-and-Growth Program for Young Scientists, Tohoku University, Sendai, 980-8579, Japan.
Karin SasakiExploring-Germination-and-Growth Program for Young Scientists, Tohoku University, Sendai, 980-8579, Japan.
Noa TakahashiExploring-Germination-and-Growth Program for Young Scientists, Tohoku University, Sendai, 980-8579, Japan.
Yukihiro ItoGraduate School of Agricultural Science, Tohoku University, Sendai, 980-8572, Japan. yukito@tohoku.ac.jp.
Tohoku University · JPSakata (Brazil) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although plants have several advantages for foreign protein production, cultivation of transgenic plants in artificial plant growth facilities involves the use of a great amount of electricity for lightning and air conditioning, reducing cost-effectiveness. Protein production in plants grown in darkness can overcome this problem, but the amount of protein produced in the dark is unknown. In this study, the total amount of soluble protein produced in rice seedlings germinated and grown in light or darkness were examined at several time points after germination and under different temperature, nutritional, and seedling density conditions. Our results indicate that rice seedlings grown in darkness produce a comparable amount of total soluble protein to those grown in light. Furthermore, we found that the best conditions for protein production in dark-grown rice seedlings are large seeds germinated and grown for 10-12 days at 28 °C supplemented with Murashige and Skoog medium and 30 g/l sucrose in dense planting. Therefore, our results suggest that foreign proteins can be produced in rice seedlings in the dark, with a reduced electricity use and an increase in cost-effectiveness.

Indexed as

OryzaSeedlingsDarknessGerminationLightSeeds

Identifiers

PMID35545638
PMCPMC9095683
OpenAlexW4280564355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.